These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7848130)

  • 1. White matter hyperintensities in Parkinson's disease. Clinical correlations.
    Piccini P; Pavese N; Canapicchi R; Paoli C; Del Dotto P; Puglioli M; Rossi G; Bonuccelli U
    Arch Neurol; 1995 Feb; 52(2):191-4. PubMed ID: 7848130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Areas of white matter hyperintensities and motor symptoms of Parkinson disease.
    Lee Y; Ko J; Choi YE; Oh JS; Kim JS; Sunwoo MK; Yoon JH; Kang SY; Hong JY
    Neurology; 2020 Jul; 95(3):e291-e298. PubMed ID: 32576636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual rating of white matter hyperintensities in Parkinson's disease.
    Beyer MK; Aarsland D; Greve OJ; Larsen JP
    Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations, white matter lesions and disease severity in Parkinson's disease.
    Kraft E; Winkelmann J; Trenkwalder C; Auer DP
    Acta Neurol Scand; 1999 Jun; 99(6):362-7. PubMed ID: 10577270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
    Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH
    Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study.
    Garde E; Mortensen EL; Krabbe K; Rostrup E; Larsson HB
    Lancet; 2000 Aug; 356(9230):628-34. PubMed ID: 10968435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and disease-related cerebral white matter changes in patients with Parkinson's disease.
    de Schipper LJ; Hafkemeijer A; Bouts MJRJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    Neurobiol Aging; 2019 Aug; 80():203-209. PubMed ID: 31207552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities.
    ten Dam VH; van den Heuvel DM; de Craen AJ; Bollen EL; Murray HM; Westendorp RG; Blauw GJ; van Buchem MA
    Radiology; 2007 Apr; 243(1):198-203. PubMed ID: 17329688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities and the progression from mild parkinsonian signs to parkinsonism and Parkinson's disease.
    Huo Y; Hong W; Huang J; Wang C; Ma J; Liu D; Chen L; Peng Z; Dong S; Tao Y; Li L; Liu L; Yang H; Zhou H
    Neurobiol Aging; 2020 Dec; 96():267-276. PubMed ID: 33130544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
    Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
    Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging.
    Leys D; Soetaert G; Petit H; Fauquette A; Pruvo JP; Steinling M
    Arch Neurol; 1990 May; 47(5):524-7. PubMed ID: 2334300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range fibre damage in small vessel brain disease affects aphasia severity.
    Wilmskoetter J; Marebwa B; Basilakos A; Fridriksson J; Rorden C; Stark BC; Johnson L; Hickok G; Hillis AE; Bonilha L
    Brain; 2019 Oct; 142(10):3190-3201. PubMed ID: 31501862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people.
    Murray AD; Staff RT; Shenkin SD; Deary IJ; Starr JM; Whalley LJ
    Radiology; 2005 Oct; 237(1):251-7. PubMed ID: 16126931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic oxidative stress and cognitive function in Parkinson's disease with different PWMH or DWMH lesions.
    Chang TC; Chen YC; Huang YC; Lin WC; Lu CH
    BMC Neurol; 2021 Jan; 21(1):16. PubMed ID: 33430806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.